Medium length banner heading goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

close icon
Bridging the Gap Between Lab and Market

Every Great Idea Deserves To Be A Successful Business

Ikove unlocks the potential of technology commercialization by identifying and vetting disruptive technologies at leading research labs and launching those into successful startups that deserve to be shared with humanity.

Background GraphicBackground Graphic

Our portfolio companies have been featured in these publications

Success by the Numbers

How we’ve grown

Our performance, from our founding in 2014 to the present:

$150M+
Invested into our portfolio of companies
$600M+
Equity value generated
20+
Companies we have helped grow into successful businesses
AssetWatch Executive Chairman & Co-Founder, Will Zell
"Having Ikove as a founding partner in Nikola Labs was extremely helpful. I had launched two tech companies previously, and the difference between those and Nikola was substantial. Ikove brought an infrastructure of support and partnership across the critical needs every startup has, from an investor network to business development and product strategy. Nikola is where it is today as a company because of the foundation Ikove helped build."
Will Zell - Executive Chairman & Co-Founder
University Researcher
The Problem – The Valley of Death

A Significant Capital Gap Exists Between University Funded R&D and VC Funded Rounds

Universities & research institutions spend over $90 billion a year in R&D, but less than 1% is invested in commercialization efforts.

Unicorn share of venture investing has skyrocketed while early stage deals have been cut in half, ~2% of all venture deals received close to 40% of all money invested in venture.

Revolutionary IP is left sitting on the shelves at leading universities, Upwards of 95% of patented university innovations go unfunded and never reach commercial market.

Our Solution

The Startup Nursery Fund allows external, strategic investors to co-invest alongside Ikove’s Nursery.

Ikove’s Startup Nursery creates businesses around the best intellectual property funded through the research budget of leading universities.

Investors can now capitalize on exclusive opportunities related to the commercialization of disruptive intellectual property and startup companies.

investor signing papers
About Us

We pursue early-stage investments with an emphasis on technology commercialization

Through our proprietary Startup Nursery, in partnership with multiple U.S. research institutions, We identify and validate developing high-impact technologies, providing capital and commercialization resources to bridge the gap between R&D and VC funded rounds.

university technology to be commercialized
In the News

The Latest News from Ikove, Our Partners and Our Portfolio Companies

Our portfolio of companies are making noise with groundbreaking innovation.

April 4, 2023
AssetWatch, Inc., a leading condition monitoring and predictive maintenance organization, has been named a Top Workplace in the Columbus C.E.O. Magazine.
February 17, 2023
January 30, 2023
"Nikola Labs unveils new name, website, and bold and distinct new visual identity as a part of an extensive rebranding initiative."
Subscribe for our News & Insights
Join our newsletter to stay up to date on features and releases.
Subscribe
By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ikove makes no warranties, express or implied, regarding any of the information on this website. None of the information on this website is investment advice. This website is not a solicitation of investment or offer to purchase or sell securities.